174 related articles for article (PubMed ID: 9660375)
1. Diminished serotonin-mediated prolactin responses in nondepressed stroke patients compared with healthy normal subjects.
Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S
Stroke; 1998 Jul; 29(7):1293-8. PubMed ID: 9660375
[TBL] [Abstract][Full Text] [Related]
2. A neuroendocrine study of serotonin function in depressed stroke patients compared to non depressed stroke patients and healthy controls.
Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S
J Affect Disord; 1999; 52(1-3):121-33. PubMed ID: 10357025
[TBL] [Abstract][Full Text] [Related]
3. Neurohormonal responses to D-fenfluramine in healthy elderly subjects. A placebo-controlled study.
Ramasubbu R; Flint A; Brown G; Awad G; Kennedy S
Psychoneuroendocrinology; 2000 Feb; 25(2):139-50. PubMed ID: 10674278
[TBL] [Abstract][Full Text] [Related]
4. Oral d-fenfluramine test in treatment-refractory depression. Plasma prolactin response compared in patients with and without suicide attempts and in a healthy reference group.
Prochazka H; Sjögren M; Agren H
J Affect Disord; 2000; 57(1-3):201-8. PubMed ID: 10708832
[TBL] [Abstract][Full Text] [Related]
5. Interrelationship of age, depression, and central serotonergic function: evidence from fenfluramine challenge studies.
Lerer B; Gillon D; Lichtenberg P; Gorfine M; Gelfin Y; Shapira B
Int Psychogeriatr; 1996; 8(1):83-102. PubMed ID: 8805090
[TBL] [Abstract][Full Text] [Related]
6. Serotonin, impulsivity, and alcohol use disorders in the older adolescent: a psychobiological study.
Soloff PH; Lynch KG; Moss HB
Alcohol Clin Exp Res; 2000 Nov; 24(11):1609-19. PubMed ID: 11104107
[TBL] [Abstract][Full Text] [Related]
7. Hormonal responses to d- and d,l-fenfluramine in healthy human subjects.
Coccaro EF; Kavoussi RJ; Cooper TB; Hauger RL
Neuropsychopharmacology; 1996 Dec; 15(6):595-607. PubMed ID: 8946434
[TBL] [Abstract][Full Text] [Related]
8. Prolactin hyperresponsiveness to D-fenfluramine in drug-free schizophrenic patients: a placebo-controlled study.
Monteleone P; Tortorella A; Borriello R; Cassandro P; Maj M
Biol Psychiatry; 1999 Jun; 45(12):1606-11. PubMed ID: 10376122
[TBL] [Abstract][Full Text] [Related]
9. Prolactin and cortisol responses to d-fenfluramine in major depression: evidence for diminished responsivity of central serotonergic function.
O'Keane V; Dinan TG
Am J Psychiatry; 1991 Aug; 148(8):1009-15. PubMed ID: 1853948
[TBL] [Abstract][Full Text] [Related]
10. Acute tryptophan depletion attenuates the prolactin response to d-fenfluramine challenge in healthy human subjects.
Coccaro EF; Kavoussi RJ; Cooper TB; Hauger R
Psychopharmacology (Berl); 1998 Jul; 138(1):9-15. PubMed ID: 9694521
[TBL] [Abstract][Full Text] [Related]
11. 5-HT brain function in affective disorder: d,l-fenfluramine-induced hormone release and clinical outcome in long-term lithium/carbamazepine prophylaxis.
Mannel M; Müller-Oerlinghausen B; Czernik A; Sauer H
J Affect Disord; 1997 Nov; 46(2):101-13. PubMed ID: 9479614
[TBL] [Abstract][Full Text] [Related]
12. Does central serotonergic function correlate inversely with aggression? A study using D-fenfluramine in healthy subjects.
Cleare AJ; Bond AJ
Psychiatry Res; 1997 Mar; 69(2-3):89-95. PubMed ID: 9109176
[TBL] [Abstract][Full Text] [Related]
13. Prolactin and cortisol responses to fenfluramine in Parkinson's disease.
Kostić VS; Lecić D; Doder M; Marinković J; Filipović S
Biol Psychiatry; 1996 Oct; 40(8):769-75. PubMed ID: 8894070
[TBL] [Abstract][Full Text] [Related]
14. Plasma oxytocin in response to pharmaco-challenge to D-fenfluramine and placebo in healthy men.
Lee R; Garcia F; van de Kar LD; Hauger RD; Coccaro EF
Psychiatry Res; 2003 May; 118(2):129-36. PubMed ID: 12798977
[TBL] [Abstract][Full Text] [Related]
15. Lack of effect of HPA axis hyperactivity on hormonal responses to d-fenfluramine in major depressed patients: implications for pathogenesis of suicidal behaviour.
Duval F; Mokrani MC; Correa H; Bailey P; Valdebenito M; Monreal J; Crocq MA; Macher JP
Psychoneuroendocrinology; 2001 Jul; 26(5):521-37. PubMed ID: 11337135
[TBL] [Abstract][Full Text] [Related]
16. Seasonal variation in plasma prolactin response to D-fenfluramine in healthy subjects.
Monteleone P; La Rocca A; Fuschino A; Bortolotti F; Maj M
Psychoneuroendocrinology; 1999 Feb; 24(2):201-8. PubMed ID: 10101728
[TBL] [Abstract][Full Text] [Related]
17. 5-HT3 receptor antagonism by ondansetron does not attenuate prolactin response to d-fenfluramine challenge in healthy human subjects.
Coccaro EF; Kavoussi RJ; Cooper TB; Hauger R
Psychopharmacology (Berl); 1996 Sep; 127(2):108-12. PubMed ID: 8888375
[TBL] [Abstract][Full Text] [Related]
18. Lack of effect of hydrocortisone treatment on d-fenfluramine-mediated prolactin release.
Young AH; Rue J; Odontiadis J; Cowen PJ
Psychopharmacology (Berl); 1998 Mar; 136(2):198-200. PubMed ID: 9551777
[TBL] [Abstract][Full Text] [Related]
19. The hormonal response to a d-fenfluramine challenge in trained and sedentary men.
Strachan AT; Maughan RJ
Med Sci Sports Exerc; 1999 Apr; 31(4):547-53. PubMed ID: 10211850
[TBL] [Abstract][Full Text] [Related]
20. Fenfluramine challenge, self-injurious behavior, and aggression in rhesus monkeys.
Tiefenbacher S; Davenport MD; Novak MA; Pouliot AL; Meyer JS
Physiol Behav; 2003 Nov; 80(2-3):327-31. PubMed ID: 14637232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
